Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) EBT Margin: 2009-2025

Historic EBT Margin for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -3.06%.

  • Lifecore Biomedical's EBT Margin rose 1580.00% to -3.06% in Q2 2025 from the same period last year, while for May 2025 it was -30.01%, marking a year-over-year decrease of 3743.00%. This contributed to the annual value of -30.01% for FY2025, which is 3743.00% down from last year.
  • Per Lifecore Biomedical's latest filing, its EBT Margin stood at -3.06% for Q2 2025, which was up 92.73% from -42.04% recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical's EBT Margin peaked at 47.02% during Q4 2023, and registered a low of -118.05% during Q2 2023.
  • Moreover, its 3-year median value for EBT Margin was -31.04% (2024), whereas its average is -27.23%.
  • In the last 5 years, Lifecore Biomedical's EBT Margin crashed by 10,446bps in 2023 and then spiked by 9,920bps in 2024.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's EBT Margin stood at 4.97% in 2021, then slumped by 4,703bps to -42.06% in 2022, then surged by 8,909bps to 47.02% in 2023, then slumped by 6,707bps to -20.05% in 2024, then skyrocketed by 1,580bps to -3.06% in 2025.
  • Its EBT Margin was -3.06% in Q2 2025, compared to -42.04% in Q1 2025 and -20.05% in Q4 2024.